Titre : Phosphocréatine

Phosphocréatine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Middle Aged
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Phosphocréatine : Questions médicales les plus fréquentes", "headline": "Phosphocréatine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Phosphocréatine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-04", "dateModified": "2026-01-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Phosphocréatine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Acides phosphoaminés", "url": "https://questionsmedicales.fr/mesh/D019606", "about": { "@type": "MedicalCondition", "name": "Acides phosphoaminés", "code": { "@type": "MedicalCode", "code": "D019606", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.125.740" } } }, "about": { "@type": "MedicalCondition", "name": "Phosphocréatine", "alternateName": "Phosphocreatine", "code": { "@type": "MedicalCode", "code": "D010725", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Zeyao Tang", "url": "https://questionsmedicales.fr/author/Zeyao%20Tang", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Dalian Medical University, Dalian, Liaoning 116044, China." } }, { "@type": "Person", "name": "Eskandar Qaed", "url": "https://questionsmedicales.fr/author/Eskandar%20Qaed", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Dalian Medical University, 9 West Section, South Road of Lushun, 116044 Dalian, China." } }, { "@type": "Person", "name": "Jiadi Xu", "url": "https://questionsmedicales.fr/author/Jiadi%20Xu", "affiliation": { "@type": "Organization", "name": "F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, MD, USA. xuj@kennedykrieger.org." } }, { "@type": "Person", "name": "Guozhu Han", "url": "https://questionsmedicales.fr/author/Guozhu%20Han", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Dalian Medical University, Dalian, Liaoning 116044, China." } }, { "@type": "Person", "name": "Mengyue Niu", "url": "https://questionsmedicales.fr/author/Mengyue%20Niu", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Dalian Medical University, Dalian, Liaoning 116044, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Visual memory and alcohol use in a middle-aged birth cohort.", "datePublished": "2024-03-13", "url": "https://questionsmedicales.fr/article/38481169", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-024-18153-1" } }, { "@type": "ScholarlyArticle", "name": "Effects of Fasting on the Physiological and Psychological Responses in Middle-Aged Men.", "datePublished": "2023-08-03", "url": "https://questionsmedicales.fr/article/37571381", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/nu15153444" } }, { "@type": "ScholarlyArticle", "name": "Number of CAG repeats and mortality in middle aged and older men.", "datePublished": "2023-09-18", "url": "https://questionsmedicales.fr/article/37718889", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cen.14962" } }, { "@type": "ScholarlyArticle", "name": "Empirical study on the factors influencing the successful aging of the middle-aged and older adult community volunteers.", "datePublished": "2023-10-04", "url": "https://questionsmedicales.fr/article/37869203", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2023.1140965" } }, { "@type": "ScholarlyArticle", "name": "Self-concealment scale (SCS) in middle-aged people: psychometric features and cross-age equivalence test.", "datePublished": "2024-09-03", "url": "https://questionsmedicales.fr/article/39227903", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-024-05991-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Acides aminés", "item": "https://questionsmedicales.fr/mesh/D000596" }, { "@type": "ListItem", "position": 4, "name": "Acides phosphoaminés", "item": "https://questionsmedicales.fr/mesh/D019606" }, { "@type": "ListItem", "position": 5, "name": "Phosphocréatine", "item": "https://questionsmedicales.fr/mesh/D010725" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Phosphocréatine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Phosphocréatine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-02-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Phosphocréatine", "description": "Comment diagnostiquer une carence en phosphocréatine ?\nQuels examens sont utilisés pour évaluer la phosphocréatine ?\nLes tests génétiques sont-ils utiles pour la phosphocréatine ?\nQuels symptômes indiquent un problème de phosphocréatine ?\nPeut-on mesurer la phosphocréatine dans l'urine ?", "url": "https://questionsmedicales.fr/mesh/D010725?mesh_terms=Middle+Aged&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Phosphocréatine", "description": "Quels sont les symptômes d'une faible phosphocréatine ?\nLa douleur musculaire est-elle liée à la phosphocréatine ?\nComment la phosphocréatine affecte-t-elle l'endurance ?\nLes troubles cognitifs peuvent-ils être liés à la phosphocréatine ?\nY a-t-il des signes de défaillance musculaire ?", "url": "https://questionsmedicales.fr/mesh/D010725?mesh_terms=Middle+Aged&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Phosphocréatine", "description": "Comment prévenir une carence en phosphocréatine ?\nLes suppléments de créatine sont-ils préventifs ?\nL'hydratation joue-t-elle un rôle dans la phosphocréatine ?\nLes périodes de repos sont-elles importantes ?\nLes activités d'endurance aident-elles à la prévention ?", "url": "https://questionsmedicales.fr/mesh/D010725?mesh_terms=Middle+Aged&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Phosphocréatine", "description": "Quels traitements existent pour la carence en phosphocréatine ?\nLa thérapie physique est-elle bénéfique ?\nLes médicaments peuvent-ils aider à la phosphocréatine ?\nComment l'alimentation influence-t-elle la phosphocréatine ?\nLes exercices spécifiques peuvent-ils améliorer la phosphocréatine ?", "url": "https://questionsmedicales.fr/mesh/D010725?mesh_terms=Middle+Aged&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Phosphocréatine", "description": "Quelles complications peuvent survenir avec une carence en phosphocréatine ?\nLa dépression peut-elle être liée à la phosphocréatine ?\nY a-t-il des risques de blessures musculaires ?\nLes maladies métaboliques sont-elles liées à la phosphocréatine ?\nDes troubles cardiaques peuvent-ils être associés ?", "url": "https://questionsmedicales.fr/mesh/D010725?mesh_terms=Middle+Aged&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Phosphocréatine", "description": "Quels facteurs augmentent le risque de carence en phosphocréatine ?\nL'âge influence-t-il les niveaux de phosphocréatine ?\nLes maladies génétiques affectent-elles la phosphocréatine ?\nLe stress a-t-il un impact sur la phosphocréatine ?\nLes athlètes sont-ils à risque de déséquilibre ?", "url": "https://questionsmedicales.fr/mesh/D010725?mesh_terms=Middle+Aged&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en phosphocréatine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et musculaires peuvent mesurer les niveaux de phosphocréatine." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer la phosphocréatine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et la spectroscopie par résonance magnétique peuvent évaluer les niveaux musculaires." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour la phosphocréatine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier des mutations affectant le métabolisme de la créatine." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème de phosphocréatine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue musculaire excessive et faiblesse peuvent signaler un déséquilibre." } }, { "@type": "Question", "name": "Peut-on mesurer la phosphocréatine dans l'urine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, la phosphocréatine est principalement mesurée dans le sang et les muscles." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une faible phosphocréatine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue rapide, crampes musculaires et diminution de la performance physique." } }, { "@type": "Question", "name": "La douleur musculaire est-elle liée à la phosphocréatine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une faible phosphocréatine peut contribuer à des douleurs musculaires après l'effort." } }, { "@type": "Question", "name": "Comment la phosphocréatine affecte-t-elle l'endurance ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une faible phosphocréatine réduit la capacité à maintenir l'effort prolongé." } }, { "@type": "Question", "name": "Les troubles cognitifs peuvent-ils être liés à la phosphocréatine ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien entre la phosphocréatine et la fonction cognitive." } }, { "@type": "Question", "name": "Y a-t-il des signes de défaillance musculaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des signes incluent une faiblesse musculaire et une récupération prolongée." } }, { "@type": "Question", "name": "Comment prévenir une carence en phosphocréatine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une alimentation équilibrée et pratiquer régulièrement des exercices." } }, { "@type": "Question", "name": "Les suppléments de créatine sont-ils préventifs ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent aider à maintenir des niveaux adéquats de phosphocréatine." } }, { "@type": "Question", "name": "L'hydratation joue-t-elle un rôle dans la phosphocréatine ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hydratation est essentielle pour le métabolisme musculaire." } }, { "@type": "Question", "name": "Les périodes de repos sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le repos permet aux muscles de récupérer et de reconstituer la phosphocréatine." } }, { "@type": "Question", "name": "Les activités d'endurance aident-elles à la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles favorisent l'utilisation efficace de la phosphocréatine dans les muscles." } }, { "@type": "Question", "name": "Quels traitements existent pour la carence en phosphocréatine ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de créatine et des modifications diététiques peuvent aider." } }, { "@type": "Question", "name": "La thérapie physique est-elle bénéfique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut améliorer la force musculaire et la récupération." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à la phosphocréatine ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de médicaments spécifiques pour traiter cette condition." } }, { "@type": "Question", "name": "Comment l'alimentation influence-t-elle la phosphocréatine ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en protéines peut augmenter les niveaux de phosphocréatine." } }, { "@type": "Question", "name": "Les exercices spécifiques peuvent-ils améliorer la phosphocréatine ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des exercices de haute intensité peuvent augmenter les réserves de phosphocréatine." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une carence en phosphocréatine ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles musculaires et une fatigue chronique." } }, { "@type": "Question", "name": "La dépression peut-elle être liée à la phosphocréatine ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre la carence en phosphocréatine et la dépression." } }, { "@type": "Question", "name": "Y a-t-il des risques de blessures musculaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une faible phosphocréatine peut augmenter le risque de blessures lors de l'effort." } }, { "@type": "Question", "name": "Les maladies métaboliques sont-elles liées à la phosphocréatine ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres peuvent contribuer à des maladies métaboliques." } }, { "@type": "Question", "name": "Des troubles cardiaques peuvent-ils être associés ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une carence en phosphocréatine peut affecter la fonction cardiaque dans certains cas." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de carence en phosphocréatine ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation pauvre en protéines et un mode de vie sédentaire augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il les niveaux de phosphocréatine ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux de phosphocréatine diminuent généralement avec l'âge." } }, { "@type": "Question", "name": "Les maladies génétiques affectent-elles la phosphocréatine ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies génétiques peuvent perturber le métabolisme de la créatine." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur la phosphocréatine ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter le métabolisme énergétique, y compris la phosphocréatine." } }, { "@type": "Question", "name": "Les athlètes sont-ils à risque de déséquilibre ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un entraînement excessif sans récupération peut entraîner un déséquilibre." } } ] } ] }

Sources (10000 au total)

Number of CAG repeats and mortality in middle aged and older men.

The androgen receptor (AR) mediates peripheral effects of testosterone. Previous data suggests an association between the number of CAG repeats in exon-1 of the AR gene and AR transcriptional activity... Follow-up data to 27 January 2018 were available for men aged 40-79 years recruited across six countries of the European Male Aging Study between 2003 and 2005. Cox proportional hazards modelling was ... One thousand nine hundred and seventy-seven men were followed up. Mean baseline age was 60 ± 11.1 years. Mean duration of follow-up was 12.2 years. At follow up 25.1% of men had died. CAG repeat lengt... Our European-wide cohort data overall found no association of androgen receptor CAG repeat number and mortality in men. However, post hoc analysis suggested that an association might be present in men...

Empirical study on the factors influencing the successful aging of the middle-aged and older adult community volunteers.

The pursuit of successful aging is currently the most important research and policy issue in an aging society. Participating in voluntary services can help middle-aged and older adults recognize the p... This study explores the factors related to middle-aged and older adult volunteering participation and their impact on successful aging.... Middle-aged and older adult volunteering from the East Taiwan Community Development Association and community care centers were taken as the research objects. Convenience sampling was used to select v... A total of 536 questionnaires were distributed of which 498 were valid and 38 invalid. The questionnaire recovery rate was 92.91%. Statistical findings include: (1) Those who perceived that their heal... This study confirms that the motivation and expectation of middle-aged and older adult to participate in volunteering will affect their continuous participation behavior and successful aging status th...

Self-concealment scale (SCS) in middle-aged people: psychometric features and cross-age equivalence test.

Individuals' concealment of negative information and privacy may lead to impaired social interactions and threatened health conditions. This study aimed to investigate the effectiveness of the Self-Co... The current research adopted the SCS, Distress Disclosure Index (DDI), Revised Cheek and Buss Shyness Scale (RCBS), Social Interaction Anxiety Scale (SIAS), Social Phobia Scale (SPS), UCLA Loneliness ... Exploratory factor analysis of the middle aged adults' data supported a single factor model. The factor loadings of SCS items ranged from 0.62 to 0.73, the commonality ranged from 0.39 to 0.53, and th... The SCS revealed favorable psychometric characteristics among the middle-aged Chinese population. The degree of self-concealment among emerging adults was higher than that of middle-aged and older peo...

Age, period, cohort effects in trends of depressive symptoms among middle-aged and older Chinese adults.

To investigate the effects of age, period, and cohort on the trends of depression; and to examine the influence of these three temporal effects on residential disparities in depression.... Using data from the China Health and Retirement Longitudinal Study (CHARLS) during 2011 to 2020, involving 77,703 respondents aged 45 years old and above. The measurement of depressive symptoms was th... CES-D scores increased with age and slightly decreased at older age. The cohort trends mostly increased except for a downward trend among those born in 1950s. As for the period effect, CES-D scores de... When age, period, cohort factors are considered, the age effects on depression dominated, and the period and cohort variations were relatively small. The residence disparities in depression reduced wi...

Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes.

Little is known about structural brain changes in type 1 diabetes (T1D) and whether there are early manifestations of a neurodegenerative condition like Alzheimer disease (AD) or evidence of premature... To evaluate neuroimaging markers of brain age and AD-like atrophy in participants with T1D in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complicatio... This cohort study leveraged data collected during the combined DCCT (randomized clinical trial, 1983-1993) and EDIC (observational study, 1994 to present) studies at 27 clinical centers in the US and ... T1D diagnosis.... Psychomotor and mental efficiency were evaluated using verbal fluency, digit symbol substitution test, trail making part B, and the grooved pegboard. Immediate memory scores were derived from the logi... This study included 416 EDIC participants with a median (range) age of 60 (44-74) years (87 of 416 [21%] were older than 65 years) and a median (range) diabetes duration of 37 (30-51) years. EDIC part... The findings of this study suggest an increase in brain aging among individuals with T1D without any early signs of AD-related neurodegeneration. These increases were associated with reduced cognitive...

Cardiovascular Risk Factors in Childhood and Adulthood and Cardiovascular Disease in Middle Age.

Recent evidence suggests that childhood levels of serum lipids, blood pressure, body mass index (BMI), and smoking contribute to adult risk of cardiovascular disease (CVD). Evidence is lacking on whet... To quantify direct and indirect effects of childhood risk factors on adult CVD via adulthood risk factors using mediation analysis, and to quantify their relative importance during different life-cour... This prospective cohort study followed participants from the US, Finland, and Australia from childhood (1970s-1990s) until 2019, with data on CVD risk factors in childhood and adulthood. Longitudinal ... The primary outcomes were fatal and nonfatal cardiovascular events in adulthood. Mediation analysis was used to estimate the direct and indirect effects of the childhood risk factors with CVD events, ... A total of 10 634 participants (4506 male participants [42.4%]; mean [SD] age at childhood visit, 13.3 [3.0] years; mean [SD] age at adulthood visit, 32.3 [6.0] years) were included in the cohort. The... In this cohort study of 10 634 participants, childhood risk factors were found to be associated both directly and indirectly to adult CVD, with the largest direct effect seen for BMI and LDL-C. These ...

Grip strength differences in middle-aged and older adults and individuals with stroke.

How the natural deterioration of aging, sex difference, and pathological effect of stroke affect the prediction of hand strength is still unknown.... This study aimed to compare and predict grip strength in both hands between normal controls (NCs) and stroke patients.... Observational, cross-sectional study.... Two urban hospitals and the community.... A total of 160 participants aged from 40 to 80 (80 NCs and stroke patients) were recruited.... The Jamar... The linear regression models of the grip strength in both right and left hands were good fits (the adjusted R... The pathological, sex, and age effects play complementary roles in predicting the grip strength in middle-aged and older adults between NCs and stroke patients.... In clinical practice, the recovery of the grip strength in stroke patients should take pathological, sex, and age effects together with the right dominant or left non-dominant hand affected into consi...